Startups
Phare Bio is an ambitious new social venture using novel AI and deep learning for antimicrobial development in partnership with Jim Collins' lab at MIT. Started in 2021 to address a looming crisis in antibiotic resistance, Phare is the recipient of Audacious Project prize to support big and potentially powerful solutions to the world’s most urgent challenges.
Overview
Employees
1-10
Founded date
2020
Mentions in press and media 5
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Nov 25, 2020 | Vaxil Bio : Announces Close of First Tranche of Previously Announced NonBrokered Private Placement for Gross Proceeds of $542,858 | VAXIL BIO LTD. ('Vaxil' or the 'Company') (TSX VENTURE: VXL), an innovative immunotherapy biotech company specializing in cancer and infectious diseases, announces that on November 23, 2020 we completed the first tranche of our previously a... |
| Nov 25, 2020 | VAXIL BIO LTD. Vaxil Bio : Announces Close of First Tranche of Previously Announced NonBrokered Private Placement for Gross Proceeds of $542,858 | VAXIL BIO LTD. ('Vaxil' or the 'Company') (TSX VENTURE: VXL), an innovative immunotherapy biotech company specializing in cancer and infectious diseases, announces that on November 23, 2020 we completed the first tranche of our previously a... |
| Nov 24, 2020 | VAXIL BIO LTD. Vaxil Bio : Announces Close of First Tranche of Previously Announced Non-Brokered Private Placement for Gross Proceeds of $542,858 | Not for distribution by US newswire or in United States NESS-ZIONA, Israel, Nov. 24, 2020 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (“Vaxil” or the “Company”) (TSX VENTURE: VXL), an innovative immunotherapy biotech company specializing in cancer a... |
| Nov 24, 2020 | Vaxil Bio : Announces Close of First Tranche of Previously Announced Non-Brokered Private Placement for Gross Proceeds of $542,858 | Not for distribution by US newswire or in United States NESS-ZIONA, Israel, Nov. 24, 2020 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (“Vaxil” or the “Company”) (TSX VENTURE: VXL), an innovative immunotherapy biotech company specializing in cancer a... |
Reviews 0
FAQ about Phare Bio
When was Phare Bio founded?
Phare Bio was founded in 2020.
What has the press written about Phare Bio?
Parsers VC has collected 5 articles mentioning Phare Bio, among them “Vaxil Bio : Announces Close of First Tranche of Previously Announced NonBrokered Private Placement for Gross Proceeds of $542,858” (Nov 25, 2020) and “VAXIL BIO LTD. Vaxil Bio : Announces Close of First Tranche of Previously Announced NonBrokered Private Placement for Gross Proceeds of $542,858” (Nov 25, 2020).
Is Phare Bio still active?
Yes, Phare Bio is active; its latest activity on Parsers VC dates from Sep 8, 2021.